RILA warns tariffs on pharma could hurt consumers
Industry warns of higher consumer costs, shortages, and unintended fallout from national security measures.
Pharmacy
Global generic drugs market to reach $594.99 billion by 2031
The combination of patent cliffs, supportive policy environments, and increasing disease prevalence is creating strong growth momentum.
Lilly to expand collaboration with Purdue University
Will include a planned investment up to a $250 million to accelerate pharmaceutical innovation.
Serve You Rx, Amazon Pharmacy team up on home delivery program
Anthony Vecchione writes that Serve You Rx members will have access to online transactions; transparent, upfront pricing; automatic refill options; 24/7 access to clinical pharmacists; customer care support; and free same-day home delivery of prescriptions in some regions.
PillSafe technology innovations protects children from prescription medication risks
The high-tech smart prescription bottle with a WiFi system, provides a way to protect children and adolescents from prescription misuse, diversion, accidental overdoses, and medication-related errors.
Bayer U.S. studies shed further light on menopause care
National surveys explore the menopause experience and need for individualized care.
NPC issues new white paper on 340B Drug Pricing Program
Increases in 340B hospital purchases are associated with $137 in additional annual employer-sponsored premium costs for single coverage and $415 for family coverage.
Thousands attend Asembia's AXS25 Specialty Pharmacy Summit in Las Vegas
Annual Conference links industry to specialty pharmacy's role at center of patient access, prescription fulfillment, and affordability.
NCPA: Any pharma tariffs should be tailored to avoid increasing shortages and costs
NCPA is urging the Trump administration to establish certain exclusions from any tariffs, incentivize U.S. manufacturing through supportive domestic and trade policies, and reform the PBM payment model to strengthen domestic supply chains and reimburse pharmacies fairly.
NACDS urges strategic tariff plan to ensure medication access
“Our members serve as healthcare lifelines in communities nationwide — we cannot afford disruptions that leave pharmacy shelves empty,” says NACDS president and CEO.
USP: Long-lasting drug shortages drive average duration higher, disrupting patient care
Persistent U.S. shortages make up most of the total, despite a decline in new shortages.
Cardinal Health releases new report on the cell and gene therapy industry
Analysis charts the emergence and future of advanced therapies.
CVS offering varied store formats to meet community needs
The goal is to have the right kind and number of stores in the right locations to better serve their customers’ needs.
New GoodRx report dives into shrinking insurance coverage
Medicaid is the most generous in coverage (97%), but also the most restrictive (63% of drugs have hurdles to access).
Camber Launches Eslicarbazepine Acetate Tablets
Eslicarbazepine Acetate Tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older.
NACDS Foundation welcomes new members to its board of directors
Directors from Unilever, Kroger Health, Inmar Intelligence, Haleon, Colgate-Palmolive, and Walmart to support the Foundation’s ongoing focus on research and education.